Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core

Michael R. Wood, Meredith J. Noetzel, Julie L. Engers, Katrina A. Bollinger, Bruce J. Melancon, James C. Tarr, Changho Han, Mary West, Alison R. Gregro, Atin Lamsal, Sichen Chang, Sonia Ajmera, Emery Smith, Peter Chase, Peter S. Hodder, Michael Bubser, Carrie K. Jones, Corey R. Hopkins, Kyle A. Emmitte, Colleen M. NiswenderMichael W. Wood, Mark E. Duggan, P. Jeffrey Conn, Thomas M. Bridges, Craig W. Lindsley

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This Letter describes the chemical optimization of a novel series of M4 positive allosteric modulators (PAMs) based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core, identified from an MLPCN functional high-throughput screen. The HTS hit was potent and selective, but not CNS penetrant. Potency was maintained, while CNS penetration was improved (rat brain:plasma Kp = 0.74), within the original core after several rounds of optimization; however, the thieno[2,3-d]pyrimidine core was subject to extensive oxidative metabolism. Ultimately, we identified a 6-fluoroquinazoline core replacement that afforded good M4 PAM potency, muscarinic receptor subtype selectivity and CNS penetration (rat brain:plasma Kp > 10). Moreover, this campaign provided fundamentally distinct M4 PAM chemotypes, greatly expanding the available structural diversity for this exciting CNS target.

Original languageEnglish (US)
Pages (from-to)3029-3033
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume26
Issue number13
DOIs
StatePublished - Jul 1 2016

Fingerprint

Modulators
Rats
Brain
Muscarinic Receptors
Plasmas
Metabolism
Throughput
thieno(2,3-d)pyrimidine

Keywords

  • M
  • Muscarinic acetylcholine receptor
  • Positive allosteric modulator (PAM)
  • Schizophrenia
  • Structure-Activity Relationship (SAR)

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core. / Wood, Michael R.; Noetzel, Meredith J.; Engers, Julie L.; Bollinger, Katrina A.; Melancon, Bruce J.; Tarr, James C.; Han, Changho; West, Mary; Gregro, Alison R.; Lamsal, Atin; Chang, Sichen; Ajmera, Sonia; Smith, Emery; Chase, Peter; Hodder, Peter S.; Bubser, Michael; Jones, Carrie K.; Hopkins, Corey R.; Emmitte, Kyle A.; Niswender, Colleen M.; Wood, Michael W.; Duggan, Mark E.; Conn, P. Jeffrey; Bridges, Thomas M.; Lindsley, Craig W.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 26, No. 13, 01.07.2016, p. 3029-3033.

Research output: Contribution to journalArticle

Wood, MR, Noetzel, MJ, Engers, JL, Bollinger, KA, Melancon, BJ, Tarr, JC, Han, C, West, M, Gregro, AR, Lamsal, A, Chang, S, Ajmera, S, Smith, E, Chase, P, Hodder, PS, Bubser, M, Jones, CK, Hopkins, CR, Emmitte, KA, Niswender, CM, Wood, MW, Duggan, ME, Conn, PJ, Bridges, TM & Lindsley, CW 2016, 'Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core', Bioorganic and Medicinal Chemistry Letters, vol. 26, no. 13, pp. 3029-3033. https://doi.org/10.1016/j.bmcl.2016.05.010
Wood, Michael R. ; Noetzel, Meredith J. ; Engers, Julie L. ; Bollinger, Katrina A. ; Melancon, Bruce J. ; Tarr, James C. ; Han, Changho ; West, Mary ; Gregro, Alison R. ; Lamsal, Atin ; Chang, Sichen ; Ajmera, Sonia ; Smith, Emery ; Chase, Peter ; Hodder, Peter S. ; Bubser, Michael ; Jones, Carrie K. ; Hopkins, Corey R. ; Emmitte, Kyle A. ; Niswender, Colleen M. ; Wood, Michael W. ; Duggan, Mark E. ; Conn, P. Jeffrey ; Bridges, Thomas M. ; Lindsley, Craig W. / Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core. In: Bioorganic and Medicinal Chemistry Letters. 2016 ; Vol. 26, No. 13. pp. 3029-3033.
@article{621b45072d754c93b3eb4af887e0876b,
title = "Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core",
abstract = "This Letter describes the chemical optimization of a novel series of M4 positive allosteric modulators (PAMs) based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core, identified from an MLPCN functional high-throughput screen. The HTS hit was potent and selective, but not CNS penetrant. Potency was maintained, while CNS penetration was improved (rat brain:plasma Kp = 0.74), within the original core after several rounds of optimization; however, the thieno[2,3-d]pyrimidine core was subject to extensive oxidative metabolism. Ultimately, we identified a 6-fluoroquinazoline core replacement that afforded good M4 PAM potency, muscarinic receptor subtype selectivity and CNS penetration (rat brain:plasma Kp > 10). Moreover, this campaign provided fundamentally distinct M4 PAM chemotypes, greatly expanding the available structural diversity for this exciting CNS target.",
keywords = "M, Muscarinic acetylcholine receptor, Positive allosteric modulator (PAM), Schizophrenia, Structure-Activity Relationship (SAR)",
author = "Wood, {Michael R.} and Noetzel, {Meredith J.} and Engers, {Julie L.} and Bollinger, {Katrina A.} and Melancon, {Bruce J.} and Tarr, {James C.} and Changho Han and Mary West and Gregro, {Alison R.} and Atin Lamsal and Sichen Chang and Sonia Ajmera and Emery Smith and Peter Chase and Hodder, {Peter S.} and Michael Bubser and Jones, {Carrie K.} and Hopkins, {Corey R.} and Emmitte, {Kyle A.} and Niswender, {Colleen M.} and Wood, {Michael W.} and Duggan, {Mark E.} and Conn, {P. Jeffrey} and Bridges, {Thomas M.} and Lindsley, {Craig W.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.bmcl.2016.05.010",
language = "English (US)",
volume = "26",
pages = "3029--3033",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "13",

}

TY - JOUR

T1 - Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core

AU - Wood, Michael R.

AU - Noetzel, Meredith J.

AU - Engers, Julie L.

AU - Bollinger, Katrina A.

AU - Melancon, Bruce J.

AU - Tarr, James C.

AU - Han, Changho

AU - West, Mary

AU - Gregro, Alison R.

AU - Lamsal, Atin

AU - Chang, Sichen

AU - Ajmera, Sonia

AU - Smith, Emery

AU - Chase, Peter

AU - Hodder, Peter S.

AU - Bubser, Michael

AU - Jones, Carrie K.

AU - Hopkins, Corey R.

AU - Emmitte, Kyle A.

AU - Niswender, Colleen M.

AU - Wood, Michael W.

AU - Duggan, Mark E.

AU - Conn, P. Jeffrey

AU - Bridges, Thomas M.

AU - Lindsley, Craig W.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - This Letter describes the chemical optimization of a novel series of M4 positive allosteric modulators (PAMs) based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core, identified from an MLPCN functional high-throughput screen. The HTS hit was potent and selective, but not CNS penetrant. Potency was maintained, while CNS penetration was improved (rat brain:plasma Kp = 0.74), within the original core after several rounds of optimization; however, the thieno[2,3-d]pyrimidine core was subject to extensive oxidative metabolism. Ultimately, we identified a 6-fluoroquinazoline core replacement that afforded good M4 PAM potency, muscarinic receptor subtype selectivity and CNS penetration (rat brain:plasma Kp > 10). Moreover, this campaign provided fundamentally distinct M4 PAM chemotypes, greatly expanding the available structural diversity for this exciting CNS target.

AB - This Letter describes the chemical optimization of a novel series of M4 positive allosteric modulators (PAMs) based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core, identified from an MLPCN functional high-throughput screen. The HTS hit was potent and selective, but not CNS penetrant. Potency was maintained, while CNS penetration was improved (rat brain:plasma Kp = 0.74), within the original core after several rounds of optimization; however, the thieno[2,3-d]pyrimidine core was subject to extensive oxidative metabolism. Ultimately, we identified a 6-fluoroquinazoline core replacement that afforded good M4 PAM potency, muscarinic receptor subtype selectivity and CNS penetration (rat brain:plasma Kp > 10). Moreover, this campaign provided fundamentally distinct M4 PAM chemotypes, greatly expanding the available structural diversity for this exciting CNS target.

KW - M

KW - Muscarinic acetylcholine receptor

KW - Positive allosteric modulator (PAM)

KW - Schizophrenia

KW - Structure-Activity Relationship (SAR)

UR - http://www.scopus.com/inward/record.url?scp=84966545988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966545988&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2016.05.010

DO - 10.1016/j.bmcl.2016.05.010

M3 - Article

C2 - 27185330

AN - SCOPUS:84966545988

VL - 26

SP - 3029

EP - 3033

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 13

ER -